Literature DB >> 25770069

Update on exercise-induced pulmonary hemorrhage.

Stacey Sullivan1, Kenneth Hinchcliff2.   

Abstract

Exercise-induced pulmonary hemorrhage (EIPH) is an important disease of horses that perform high-intensity athletic activity. EIPH is an ongoing concern for the racing industry because of its high prevalence; potential impact on performance; welfare concerns; and use of prophylactic medications, such as furosemide, on race day. During the last 10 years, significant progress has been made in understanding the pathogenesis and risk factors for EIPH and the impact of the disease on performance and career. This article summarizes the most recent advances in EIPH.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bleeding; Epistaxis; Equine; Performance; Welfare

Mesh：

Year:  2015        PMID： 25770069     DOI： 10.1016/j.cveq.2014.11.011

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN： 0749-0739            Impact factor:   1.792


  9 in total

1.  Tracheobronchoscopic Assessment of Exercise-Induced Pulmonary Hemorrhage and Airway Inflammation in Barrel Racing Horses.

Authors:  R Léguillette; M Steinmann; S L Bond; B Stanton
Journal:  J Vet Intern Med       Date:  2016-06-08       Impact factor: 3.333

2.  Exercise-induced pulmonary hemorrhage in barrel racing horses in the Pacific Northwest region of the United States.

Authors:  Jenifer R Gold; Donald P Knowles; Todd Coffey; Warwick M Bayly
Journal:  J Vet Intern Med       Date:  2018-02-20       Impact factor: 3.333

3.  Endurance Exercise Ability in the Horse: A Trait with Complex Polygenic Determinism.

Authors:  Anne Ricard; Céline Robert; Christine Blouin; Fanny Baste; Gwendoline Torquet; Caroline Morgenthaler; Julie Rivière; Nuria Mach; Xavier Mata; Laurent Schibler; Eric Barrey
Journal:  Front Genet       Date:  2017-06-28       Impact factor: 4.599

4.  Exercise-induced pulmonary hemorrhage: where are we now?

Authors:  David C Poole; Howard H Erickson
Journal:  Vet Med (Auckl)       Date:  2016-11-21

Review 5.  Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.

Authors:  Christopher J Rogers; Robert J Harman; Bruce A Bunnell; Martin A Schreiber; Charlie Xiang; Fu-Sheng Wang; Antonio F Santidrian; Boris R Minev
Journal:  J Transl Med       Date:  2020-05-18       Impact factor: 5.531

6.  Pulmonary bleeding in racehorses: A gross, histologic, and ultrastructural comparison of exercise-induced pulmonary hemorrhage and exercise-associated fatal pulmonary hemorrhage.

Authors:  Guido Rocchigiani; Ranieri Verin; Francisco A Uzal; Ellen R Singer; Paola Pregel; Lorenzo Ressel; Emanuele Ricci
Journal:  Vet Pathol       Date:  2022-08-16       Impact factor: 3.157

7.  Association between exercise-induced pulmonary hemorrhage and inflammatory airway disease in polo ponies.

Authors:  Katia Moreira da Silva; Juliana Nabuco Pereira Otaka; Carlos Alexandre Paula Gonçalves; Estevão Grossi Aguiar Silva; Nayro Xavier de Alencar; Daniel Augusto Barroso Lessa
Journal:  J Equine Sci       Date:  2017-07-06

8.  Pharmacokinetic and pharmacodynamic properties of orally administered torsemide in healthy horses.

Authors:  Gustavo F Agne; Seung Woo Jung; Anne A Wooldridge; Susan H Duran; William Ravis; Ramiro Toribio
Journal:  J Vet Intern Med       Date:  2018-05-17       Impact factor: 3.333

9.  Relationship between tracheobronchoscopic score and bronchoalveolar lavage red blood cell numbers in the diagnosis of exercise-induced pulmonary hemorrhage in horses.

Authors:  Carolina M Lopez Sanchez; Clark Kogan; Jenifer R Gold; Debra C Sellon; Warwick M Bayly
Journal:  J Vet Intern Med       Date:  2019-12-27       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.